Novelix Pharmaceuticals Statistics
Total Valuation
BOM:536565 has a market cap or net worth of INR 987.50 million. The enterprise value is 973.00 million.
| Market Cap | 987.50M |
| Enterprise Value | 973.00M |
Important Dates
The next estimated earnings date is Wednesday, February 11, 2026.
| Earnings Date | Feb 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:536565 has 17.62 million shares outstanding. The number of shares has increased by 53.46% in one year.
| Current Share Class | 17.62M |
| Shares Outstanding | 17.62M |
| Shares Change (YoY) | +53.46% |
| Shares Change (QoQ) | +21.19% |
| Owned by Insiders (%) | 41.75% |
| Owned by Institutions (%) | 1.42% |
| Float | 3.49M |
Valuation Ratios
The trailing PE ratio is 73.89.
| PE Ratio | 73.89 |
| Forward PE | n/a |
| PS Ratio | 1.16 |
| PB Ratio | 3.86 |
| P/TBV Ratio | 3.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 75.83, with an EV/FCF ratio of -6.23.
| EV / Earnings | 102.50 |
| EV / Sales | 1.15 |
| EV / EBITDA | 75.83 |
| EV / EBIT | 79.10 |
| EV / FCF | -6.23 |
Financial Position
The company has a current ratio of 1.53
| Current Ratio | 1.53 |
| Quick Ratio | 1.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 5.49% and return on invested capital (ROIC) is 4.64%.
| Return on Equity (ROE) | 5.49% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 4.64% |
| Return on Capital Employed (ROCE) | 4.80% |
| Weighted Average Cost of Capital (WACC) | 6.48% |
| Revenue Per Employee | 106.13M |
| Profits Per Employee | 1.19M |
| Employee Count | 8 |
| Asset Turnover | 2.02 |
| Inventory Turnover | 48.72 |
Taxes
In the past 12 months, BOM:536565 has paid 2.78 million in taxes.
| Income Tax | 2.78M |
| Effective Tax Rate | 22.64% |
Stock Price Statistics
The stock price has increased by +124.85% in the last 52 weeks. The beta is 0.41, so BOM:536565's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +124.85% |
| 50-Day Moving Average | 58.67 |
| 200-Day Moving Average | 41.83 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 10,661 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:536565 had revenue of INR 849.03 million and earned 9.49 million in profits. Earnings per share was 0.76.
| Revenue | 849.03M |
| Gross Profit | 26.19M |
| Operating Income | 12.30M |
| Pretax Income | 12.27M |
| Net Income | 9.49M |
| EBITDA | 12.83M |
| EBIT | 12.30M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 14.50 million in cash and n/a in debt, with a net cash position of 14.50 million or 0.82 per share.
| Cash & Cash Equivalents | 14.50M |
| Total Debt | n/a |
| Net Cash | 14.50M |
| Net Cash Per Share | 0.82 |
| Equity (Book Value) | 256.10M |
| Book Value Per Share | 17.77 |
| Working Capital | 244.26M |
Cash Flow
In the last 12 months, operating cash flow was -145.47 million and capital expenditures -10.73 million, giving a free cash flow of -156.21 million.
| Operating Cash Flow | -145.47M |
| Capital Expenditures | -10.73M |
| Free Cash Flow | -156.21M |
| FCF Per Share | -8.87 |
Margins
Gross margin is 3.08%, with operating and profit margins of 1.45% and 1.12%.
| Gross Margin | 3.08% |
| Operating Margin | 1.45% |
| Pretax Margin | 1.45% |
| Profit Margin | 1.12% |
| EBITDA Margin | 1.51% |
| EBIT Margin | 1.45% |
| FCF Margin | n/a |
Dividends & Yields
BOM:536565 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -53.46% |
| Shareholder Yield | -53.46% |
| Earnings Yield | 0.96% |
| FCF Yield | -15.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |